Literature DB >> 19925929

Pain associated with aminolevulinic acid-photodynamic therapy of skin disease.

Christine B Warren1, Laszlo J Karai, Allison Vidimos, Edward V Maytin.   

Abstract

BACKGROUND: Pain during topical aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) limits the use of this treatment of skin diseases.
OBJECTIVE: We sought to summarize the effectiveness of interventions to reduce ALA-PDT-related pain, and to explore factors contributing to pain induction.
METHODS: A PubMed search was performed to identify all clinical PDT trials (2000-2008) that used ALA or methyl-ALA, enrolled at least 10 patients per trial, and used a semiquantitative pain scale.
RESULTS: In all, 43 articles were identified for review. Pain intensity is associated with lesion size and location and can be severe for certain diagnoses, such as plaque-type psoriasis. Results are inconsistent for the correlation of pain with light source, wavelength of light, fluence rate, and total light dose. Cooling represents the best topical intervention. LIMITATIONS: Pain perception differs widely between patients and can contribute to variability in the reported results.
CONCLUSION: Gamma-aminobutyric acid receptors, cold/menthol receptors (transient receptor potential cation channel, subfamily M, member 8), and vanilloid/capsaicin receptors (transient receptor potential cation channel, subfamily V, member 1) may be involved in pain perception during ALA-PDT and are therefore worthy of further investigation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19925929      PMCID: PMC3529571          DOI: 10.1016/j.jaad.2009.03.048

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  78 in total

1.  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial.

Authors:  I Wang; N Bendsoe; C A Klinteberg; A M Enejder; S Andersson-Engels; S Svanberg; K Svanberg
Journal:  Br J Dermatol       Date:  2001-04       Impact factor: 9.302

Review 2.  Porphyrins, porphyrin metabolism and porphyrias. IV. Pathophysiology of erythyropoietic protoporphyria--diagnosis, care and monitoring of the patient.

Authors:  S Thunell; P Harper; A Brun
Journal:  Scand J Clin Lab Invest       Date:  2000-11       Impact factor: 1.713

3.  Pain caused by photodynamic therapy of skin cancer.

Authors:  S Grapengiesser; M Ericson; F Gudmundsson; O Larkö; A Rosén; A-M Wennberg
Journal:  Clin Exp Dermatol       Date:  2002-09       Impact factor: 3.470

4.  Anandamide activates vanilloid receptor 1 (VR1) at acidic pH in dorsal root ganglia neurons and cells ectopically expressing VR1.

Authors:  Z Olah; L Karai; M J Iadarola
Journal:  J Biol Chem       Date:  2001-05-01       Impact factor: 5.157

5.  Pain associated with photodynamic therapy using 5-aminolevulinic acid or 5-aminolevulinic acid methylester on tape-stripped normal skin.

Authors:  Stine Regin Wiegell; Ida-Marie Stender; Renhua Na; Hans Christian Wulf
Journal:  Arch Dermatol       Date:  2003-09

6.  Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources.

Authors:  C Clark; A Bryden; R Dawe; H Moseley; J Ferguson; S H Ibbotson
Journal:  Photodermatol Photoimmunol Photomed       Date:  2003-06       Impact factor: 3.135

7.  Laser-mediated photodynamic therapy of actinic keratoses.

Authors:  Macrene R Alexiades-Armenakas; Roy G Geronemus
Journal:  Arch Dermatol       Date:  2003-10

8.  Kinetics of the superficial perfusion and temperature in connection with photodynamic therapy of basal cell carcinomas using esterified and non-esterified 5-aminolaevulinic acid.

Authors:  S Pålsson; L Gustafsson; N Bendsoe; M Soto Thompson; S Andersson-Engels; K Svanberg
Journal:  Br J Dermatol       Date:  2003-06       Impact factor: 9.302

9.  Cold air analgesia in photodynamic therapy of basal cell carcinomas and Bowen's disease: an effective addition to treatment: a pilot study.

Authors:  John Pagliaro; Tim Elliott; Max Bulsara; Camilla King; Carl Vinciullo
Journal:  Dermatol Surg       Date:  2004-01       Impact factor: 3.398

10.  Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease.

Authors:  A Salim; J A Leman; J H McColl; R Chapman; C A Morton
Journal:  Br J Dermatol       Date:  2003-03       Impact factor: 9.302

View more
  17 in total

1.  A prospective study of pain control by a 2-step irradiance schedule during topical photodynamic therapy of nonmelanoma skin cancer.

Authors:  Nathalie C Zeitouni; Ulas Sunar; Daniel J Rohrbach; Anne D Paquette; David A Bellnier; Yi Shi; Gregory Wilding; Thomas H Foster; Barbara W Henderson
Journal:  Dermatol Surg       Date:  2014-12       Impact factor: 3.398

2.  Noninvasive fluorescence monitoring of protoporphyrin IX production and clinical outcomes in actinic keratoses following short-contact application of 5-aminolevulinate.

Authors:  Christine B Warren; Sara Lohser; Lauren C Wene; Brian W Pogue; Philip L Bailin; Edward V Maytin
Journal:  J Biomed Opt       Date:  2010 Sep-Oct       Impact factor: 3.170

3.  Assessing daylight & low-dose rate photodynamic therapy efficacy, using biomarkers of photophysical, biochemical and biological damage metrics in situ.

Authors:  Ana Luiza Ribeiro de Souza; Ethan LaRochelle; Kayla Marra; Jason Gunn; Scott C Davis; Kimberley S Samkoe; M Shane Chapman; Edward V Maytin; Tayyaba Hasan; Brian W Pogue
Journal:  Photodiagnosis Photodyn Ther       Date:  2017-10-14       Impact factor: 3.631

Review 4.  Vitamin D and Other Differentiation-promoting Agents as Neoadjuvants for Photodynamic Therapy of Cancer.

Authors:  Edward V Maytin; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2020-04-15       Impact factor: 3.421

5.  Painless versus conventional photodynamic therapy for treatment of actinic keratosis: Comparison of cell death and immune response in a murine model.

Authors:  Sanjay Anand; Anton Yasinchak; Mukul Govande; Sajina Shakya; Edward V Maytin
Journal:  Proc SPIE Int Soc Opt Eng       Date:  2019-02-28

Review 6.  Biomodulatory approaches to photodynamic therapy for solid tumors.

Authors:  Sanjay Anand; Bernhard J Ortel; Stephen P Pereira; Tayyaba Hasan; Edward V Maytin
Journal:  Cancer Lett       Date:  2012-07-25       Impact factor: 8.679

7.  A retrospective review of pain control by a two-step irradiance schedule during topical ALA-photodynamic therapy of non-melanoma skin cancer.

Authors:  Nathalie C Zeitouni; Anne D Paquette; Joseph P Housel; Yi Shi; Gregory E Wilding; Thomas H Foster; Barbara W Henderson
Journal:  Lasers Surg Med       Date:  2013-02-06       Impact factor: 4.025

8.  Vitamin D Combined with Aminolevulinate (ALA)-Mediated Photodynamic Therapy (PDT) for Human Psoriasis: A Proof-of-Principle Study.

Authors:  Edward V Maytin; Golara Honari; Amor Khachemoune; Charles R Taylor; Bernhard Ortel; Brian W Pogue; Nathaniel Sznycer-Taub; Tayyaba Hasan
Journal:  Isr J Chem       Date:  2012-08-21       Impact factor: 3.333

9.  Blue light versus red light for photodynamic therapy of basal cell carcinoma in patients with Gorlin syndrome: A bilaterally controlled comparison study.

Authors:  Edward V Maytin; Urvashi Kaw; Muneeb Ilyas; Judith A Mack; Bo Hu
Journal:  Photodiagnosis Photodyn Ther       Date:  2018-02-19       Impact factor: 3.631

10.  A regimen to minimize pain during blue light photodynamic therapy of actinic keratoses: Bilaterally controlled, randomized trial of simultaneous versus conventional illumination.

Authors:  Urvashi Kaw; Muneeb Ilyas; Taylor Bullock; Lisa Rittwage; Margo Riha; Allison Vidimos; Bo Hu; Christine B Warren; Edward V Maytin
Journal:  J Am Acad Dermatol       Date:  2019-09-13       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.